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Potentially Inappropriate Medications for Older Adults in Dental 
Practice
Objective: The present study aimed to review the medications 
frequently prescribed in dental practice that are potentially inap-
propriate for the elderly population due to the risks presented. 
Methods: An integrative literature review was carried out, based 
on the Guidance Manual: Prescription and Dispensing of Medi-
cines Used in Dentistry, which reports the main drugs prescribed 
in dental practice (2017). From this, medications described in the 
Beers list of the American Society of Geriatrics (2019) were ex-
tracted, in order to identify medications that are potentially inap-
propriate in the elderly, what are the main consequences of use 
and appropriate management in view of the need for prescription. 
Results: The prescription and dispensing guidance manual for 
medicines used in dentistry has a list of 142 medicines, contain-
ing anti-inflammatories, antibacterials, opioids, benzodiazepines 
and other types of drugs. Of the drugs listed, 27 are considered 
inadequate and the most common therapeutic class among the 
drugs was anti-inflammatory drugs, being equivalent to 44.5% of 
the inadequacies found. Conclusion: Despite the risks associat-
ed with medications, it appears that they are widely prescribed in 
dental practice, making these groups worthy of special attention 
due to their potential for serious adverse events and negative 
impacts on the elderly and the health system, in addition to to 
emphasize the importance of the professional regarding the best 
indications and pharmacotherapeutic follow-up by the clinical 
pharmacist in caring for the elderly.
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Aged.
Anna Carolinne Santana Neves, Aurylanne Mikaelle Brandão Silva, José Monteiro dos 
Santos, Lara Rebelo de Almeida
Residência Multiprofissional em Saúde, Universidade Federal de Pernambuco
ABSTRACT
IJOAR: https://escipub.com/international-journal-of-aging-research/                     1
Anna Carolinne Santana Neves et al., IJOAR, 2021 4:83 
IJOAR: https://escipub.com/international-journal-of-aging-research/                      2
INTRODUCTION  
In Brazil, there is an increase in life expectancy 
justified by public health actions, such as 
vaccination and basic sanitation, and medical 
and technological advances. The urbanization 
and family planning processes also contributed 
to reducing the fertility rate, probably by 
increasing the proportion of people over 65 
years old. This change in the population profile 
demands improvements in the health care 
model, especially with regard to pharmaceutical 
assistance, with knowledge and training of 
professionals for the care of this type of patient 
[1]. 
The general elderly patient is affected by a 
greater number of diseases, especially as 
chronic noncommunicable diseases, patient due 
to the high consumption of drugs and the risks of 
drug interactions due to the practice of 
polypharmacy [1,2]. It is also updated by 
physiological changes inherent to aging, which 
compromise the pharmacokinetics and 
pharmacodynamics of drugs and lead to greater 
sensitivity to both therapeutic and adverse 
effects. [1.3] 
The growth of the elderly population contributed 
to the increase in the demand for dental care for 
this patient profile, therefore, the dentist's 
knowledge about medicines is of fundamental 
importance for the guidelines for prescribing 
drugs in rational clinical practice. Even if in 
dentistry the drugs are prescribed for a short 
period, do not prevent the occurrence of drug 
interactions with the other drugs already used by 
the patient, as well as the possible appearance 
of adverse reactions and / or intoxications. [4.5] 
Anxiolytics, analgesics, antibiotics and non-
steroidal anti-inflammatory drugs [NSAIDs] are 
classes of medicines prescribed daily by dental 
surgeons [5]. However, some drugs are 
considered unsuitable for use in the elderly due 
to lack of effectiveness, or the greater risk of 
adverse effects that outweighs their benefits 
when compared to other categories of drugs. [1] 
Thus, this study aimed to review the drugs 
frequently prescribed in dental practice that are 
potentially inappropriate for the elderly 
population due to the high risks. 
METHODS  
This is an integrative literature review, based on 
the Guidance Manual: Prescription and 
Dispensing of Medicines Used in Dentistry 
[2017], published by the Regional Pharmacy 
Council of the state of São Paulo in partnership 
with the Regional Council of Dentistry of São 
Paulo, who reports the main drugs prescribed in 
dental practice. After extracting the frequently 
prescribed drugs, the Beers List of the American 
Society of Geriatrics [2019] was used as a basis 
for identifying drugs of potentially inappropriate 
use in elderly patients, what are the main 
consequences of misuse and adequate 
management in view of the need for prescription. 
RESULTS 
The guidance manual for prescribing and 
dispensing medicines used in dentistry has a list 
of 142 medicines, containing anti-
inflammatories, antibacterials, opioids, 
benzodiazepines and other types of drugs, as 
shown in Chart 1. 
Chart 2 shows potentially inappropriate 
medications for elderly patients among the drugs 
frequently prescribed by dentists according to 
the Beers List of the American Society of 
Geriatrics [2019]. Of the drugs listed, 27 are 
considered inadequate and the most common 
therapeutic class among the drugs was anti-
inflammatory drugs, being equivalent to 44.5% 
of the inadequacies found. Also according to the 
American Society of Geriatrics [2019], Chart 3 
presents the main consequences of misuse and 
adequate management in view of the need for 
prescription. 
DISCUSSION  
According to a study, the therapeutic classes 
most prescribed by the dentist are analgesics, 
followed by antibiotics and anti-inflammatory 
drugs [2]. Although NSAIDs accounted for 
44.5% of inappropriate drugs prescribed by 
dentists for the geriatric population, they are 
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among the most widely used therapeutic agents 
worldwide, with large consumers being elderly. 
These drugs act by inhibiting the synthesis of 
prostaglandins and thromboxanes and have 
anti-inflammatory, antipyretic and analgesic 
effects, favoring the relief of the level of pain or 
moderate caused by acute and chronic 
inflammation in the patient, especially in pain 
caused by the inflammatory process or tissue 
injury [6]. 
 
Chart 1: Drugs prescribed in dental practice. 
Aceclofenac; Acyclovir; Acetylsalicylic acid; Aminocaproic acid; Mefenamic acid; Paraminobenzoic acid; Peracetic 
acid [2%]; Tranexamic acid; Trichloroacetic acid; Alprazolam; Amikacin; Amitripline; Amoxicillin; Amoxicillin/Clavulanic 
acid; Ampicillin; AmicilliSulbactam; Amphotericin B; Articaine; Bupivacaine; Carbamazepine; Carbenicillin; Cefaclor; 
Cefadroxil; Cephalexin; Cephalothin; Cefazolin; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; 
Cefuroxime; Celecoxib; Cetirizine; Ketoprofen; Ketorolac; Cevimeline; Cyclobenzaprine; Ciprofloxacin; 
Clarithromycin; Clindamycin; Cetylpyridinium chloride; Chlorhexidine; Clobetasol; Cloxazolam; Codeine; Cortisone; 
Dehydroepiandrosterone [Androstenolone]; Desloratidine; Dexamethasone; Diazepam; Diclofenac; Dicloxacillin; 
Diphenhydramine; Diflunisal; Dipyrone; Doxicillin; Eltrombopague olamine; Epinephrine; Erythromycin; Ertapenem; 
Ethylstrenol; Etodolac; Etoricoxib; Phenylbutazone; Fenoprofen; Fentanyl; Fluconazole; Flunitrazepam; Desensitizing 
fluoride; Fluorides; Fluoxetine; Formaldhyde; Gabapentin; Gemifloxacin; Gentamycin; Glucago; Hydrocortisone; 
Ibuprofen; Imipeném; Indomentacin; Itraconazole; Levofloxacin; Lidocaine; Loratadine; Lorazepam; Sodium 
meclofenamate; Meloxicam; Mepivacaine; Meropenem; Methicillin; Methylprednisolone; Metronidazole; Miconazole; 
Midazolam; Minocycline; Morphine; Moxifloxacin; Nanohydroxyapatite; Naproxen; Nimesulid; Nystatin; Potassium 
nitrate; Nortripillin; Orfenadrin; Oxacillin; Oxazepam; Oxifembutazon; Paracetamol; Parametasone; Parecoxib; 
Penciclovir; Carbamide peroxide; Hydrogen peroxide; Pilocarpine; Piperacillin; Piperacillin/Tazobactam; Piroxicam; 
Prednisolone; Prednisone; Pregabalin; Prilocaine; Promethazine; Ramoplanin; Ranitidine; Rifamide; Roxithromycin; 
Somatropin; Sulfacetamide; Sulfadiazine; Sulfafurazole; Sulfamethoxazole; Sulindaco; Teicoplanin; Telithromycin; 
Tenoxicam; Tetracycline; Ticarcillin; Ticarcillin/Clavulanic acid; Thiocolchicoside; Tramadol; Triamcinolone; Triclosan; 
Trimethoprim; Vancomycin; Venlafaxine; Xylitol..  
Source: Guidance Manual: Prescription and Dispensing of Medicines Used in Dentistry [2017]. 
 
Chart 2: Potentially inappropriate drugs for the elderly. 
Source: American Society of Geriatrics [2019]. 
 




medication for the 
elderly 
Use in dental 
practice 
Risck according to 
Beers List [2019]  
Recommendations according to 
Beers list [2019] 
Ketoprofen Anti-inflammatory Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
Ketoprofen; Ketorolac; Cyclobenzaprine; Ciprofloxacin; Diazepam; Diclofenac; Diflunisal; Etodolac; Fenoprofen; 
Gabapentin; Ibuprofen; Indomentacin; Lorazepam; Sodium meclofenamate; Meloxicam; Morphine; Naproxen; 
Nortripillin; Orfenadrin; Oxazepam; Piroxicam; Pregabalin; Promethazine; Ranitidine; Sulindaco; Tramadol; 
Trimethoprim. 
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effective and the patient can use 
gastroprotectants.  
Ketorolac Anti-inflammatory Increased risk of 
gastrointestinal 
bleeding and acute 
kidney injury. 
Avoid. 
Cyclobenzaprine Treatment of 
temporomandibular 







risk of fractures.  
Avoid. 
Ciprofloxacino Bacterial infectious 
processes. 
Increased risk of 
CNS* effects 
[seizures, confusion] 
and tendon rupture.  
Dosage reduction [CrCl <30mL/min] 
Diazepam In cases of incidence 
of the fear, anxiety, 
phobia fator, among 
others, which trigger 
systemic conditions 
unfavorable to clinical 




Increased risk of 
cognitive impairment, 
delirium, falls and 
fractures. 
Avoid. 
Diclofenac Pain control and anti-
inflammatory. 
Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Diflunisal Pain control. Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Etodolaco Anti-inflammatory. Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Phenoprofen Anti-inflammatory. Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Gabapentina Pain control used in 
painful orofacial 
disorders. 
Increased risk of 
CNS* effects.  
Dosage reduction [CrCl<60 mL/min]. 




bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Indomethacin Anti-inflammatory. Increased risk of 
gastrointestinal 




Lorazepam In cases of incidence 
of the fear, anxiety, 
phobia fator, among 
others, which trigger 
systemic conditions 
unfavorable to clinical 




Increased risk of 
cognitive impairment, 
delirium, falls and 
fractures.  
Avoid 
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bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Meloxicam Pain control and anti-
inflammatory. 
Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Morphine Pain control for 
hospital use, to 
relieve severe and/or 
very intense pain. 




Avoid overuse for pain control in the 
acute pain environment [for example, 
recente fractures or joint replacement]. 
Consider reducing the use of other 
active CNS* medications that increase 
the risk of fracture [example: 
antiepileptics, opioid receptor agonists, 
antipsychotics, antidrepressants and 
benzodiazepines]. 
Naproxen Pain control and anti-
inflammatory. 
Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where alternatives are not effective and 
the patient can use gastroprotectants. 
Nortriptyline Coadjuvant in the 
treatment and control 
of chronic pain.  
Highly 
anticholinergic, 




Orphenadrine Treatment of 
temporomandibular 
dysfunction [TMD] 







risk of fractures. 
Avoid. 
Oxazepam In cases of incidence 
of the fear, anxiety, 
phobia fator, among 
others, which trigger 
systemic conditions 
unfavorable to clinical 




Increased risk of 
cognitive impairment, 
delirium, falls and 
fractures. 
Avoid. 
Piroxicam Pain control and anti-
inflammatory. 
Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Pregabalin Pain control used in 
painful orofacial 
disorders. 
Increased risk of 
CNS* effects.  
Dosage reduction [CrCl<60 mL/min]. 




effects or toxicity. 
Avoid. 
Ranitidine Gastric irritation. It can cause, induce 
or aggravate delirium.  
Avoid. 
Sulindaco Anti-inflammatory. Gastrointestinal 
bleeding, peptic ulcer 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
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Tramadol Pain control. It can exacerbate or 
cause SIADH or 
hyponatremia. 
Avoid chronic use, except in cases 
where other alternatives are not 
effective and the patient can use 
gastroprotectants. 
Trimethoprim Infectious or bacterial 
processes.  
Increased risk of 
hyperkalaemia when 
used simultaneously 
with na ACEI* or 
BRA* in the presence 
of decrease 
creatinine clearance.  
Use with care. 
*CNS: Central Nervous System; ACEI: Antiotensin-Converting Enzyme Inhibitors; BRA: Angiotensin receptor blockers. 
Source: American Society of Geriatrics [2019]. 
 
Regarding adverse drug reactions [ADRs], 
NSAIDs are among its main causes, being 
responsible for 20 to 25% of ADRs. Non-
selective NSAIDs for cyclooxygenase inhibit the 
production of prostaglandins in the 
gastrointestinal mucosa, which can cause 
abdominal discomfort and pain, gastric ulcer and 
even digestive bleeding. Selective COX-2 
inhibitors are safer in the gastric aspect, but 
increase the risk of cardiovascular 
complications, especially in users with a 
predisposition to diseases. Therefore, these 
drugs need to be administered with caution, 
especially in elderly patients. [7, 8] 
In general, as water-soluble drugs administered 
orally, they may have increased bioavailability 
due to the lower water content in the body, which 
leads to a reduction in their volume of 
distribution. Fat-soluble drugs, in turn, as is the 
case with Diazepam, have the highest volume of 
distribution in the elderly, as a proportion of 
adipose tissue is not higher. An equally 
important factor seen in elderly patients is 
related to the plasma concentration of albumin, 
which tends to be lower, making the binding of 
drugs to these proteins also reduced, defeating 
a greater free fraction of the drug in the plasma 
and a greater volume of distribution. [1] 
Still, alterations associated with the hepatic and 
renal systems are common. Waiting for the 
hepatic blood flow to be usually decreased, there 
is a reduction in the first-pass metabolism of the 
drugs. Renal reduction may also be impaired, 
prolonging the plasma half-life of drugs and 
increasing the likelihood of causing toxic effects.
[1]
CONCLUSION
Potentially inappropriate drugs were found for
elderly patients in the anti-inflammatory, opioid,
benzodiazepine, antibacterial, antidepressant,
antiallergic, anticonvulsant and H2 receptor
antagonist classes. Despite the risks associated
with the use of medications, it appears that they
are widely prescribed in dental practice, making
these groups worthy of special attention due to
their potential for serious adverse events and
negative impacts on the elderly and the health
system, in addition to to emphasize the
importance of the professional regarding the
best indications and pharmacotherapeutic
follow-up by the clinical pharmacist in caring for
the elderly.
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